Kramer Levin provides its clients proactive, creative and pragmatic solutions that address today’s most challenging legal issues. The firm is headquartered in New York with offices in Silicon Valley and Paris and fosters a strong culture of involvement in public and community service. For more information, visit www.kramerlevin.com
Head of Life Sciences Irena Royzman and associate Jeffrey Coleman authored a Law360 article titled "Exploring The Amgen Genus Claims Headed To High Court" on Jan. 10, 2023.
United StatesFood, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.
Head of Life Sciences Irena Royzman and associate Jeffrey
Coleman authored a Law360 article titled
“Exploring The Amgen Genus Claims Headed To High Court”
on Jan. 10, 2023. The article reviews whether generic claims in the
chemical and biological arts are alive and well as the U.S. Court
of Appeals for the Federal Circuit has explained in its
2021 Amgen Inc. v. Sanofi decision, as well as
the hurdles faced by claiming biological materials by desired
function rather than a structure shared by the biological
materials.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
